US funding sees Covid-19 antibody trial enter next phase
UK pharmaceuticals group AstraZeneca said on Monday it will advance trials of a Covid-19 treatment to a crucial third stage, after the United States invested $486 million (411 million euros) in its development.
Oct 12, 2020
0
0